Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Hopkins

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Dermatology Online Journal|October 19, 2022
Blastic plasmacytoid dendritic cell neoplasm presenting as violaceous forehead plaqueGeorgia Mae Morrison, Amy Hopkins, Calvin Knapp, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 23, 2011
The career trajectories of health care professionals practicing with permanent disabilitiesLeslie Neal-Boylan, Amy Hopkins, Rachel Skeete, et al.
British Journal of Cancer|November 6, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): cost-effectiveness and budget impact analysisPaola Cocco, Chris Bojke, Claire Hulme, et al.
Trials|August 28, 2025
Sugammadex or Neostigmine for prevention of post-operative pulmonary complications after major abdominal or thoracic surgery: study protocol for the SINFONIA (Sugammadex for preventioN oF pOst-operative pulmonary complIcAtions) randomised controlled superiority trialJonathan A Silversides, Louise Savic, Louise Hiller, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2019
Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhoodMohammed Ata Ur Rasheed, Carole J Hickman, Marcia McGrew, et al.
Health Technology Assessment (Winchester, England)|May 12, 2026
Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCTJanet Dunn, Peter Donnelly, Andrea Marshall, et al.
Lancet (London, England)|February 1, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trialJanet A Dunn, Peter Donnelly, Nada Elbeltagi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Dermatology Online Journal|October 19, 2022
Blastic plasmacytoid dendritic cell neoplasm presenting as violaceous forehead plaqueGeorgia Mae Morrison, Amy Hopkins, Calvin Knapp, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 23, 2011
The career trajectories of health care professionals practicing with permanent disabilitiesLeslie Neal-Boylan, Amy Hopkins, Rachel Skeete, et al.
British Journal of Cancer|November 6, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): cost-effectiveness and budget impact analysisPaola Cocco, Chris Bojke, Claire Hulme, et al.
Trials|August 28, 2025
Sugammadex or Neostigmine for prevention of post-operative pulmonary complications after major abdominal or thoracic surgery: study protocol for the SINFONIA (Sugammadex for preventioN oF pOst-operative pulmonary complIcAtions) randomised controlled superiority trialJonathan A Silversides, Louise Savic, Louise Hiller, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2019
Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhoodMohammed Ata Ur Rasheed, Carole J Hickman, Marcia McGrew, et al.
Health Technology Assessment (Winchester, England)|May 12, 2026
Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCTJanet Dunn, Peter Donnelly, Andrea Marshall, et al.
Lancet (London, England)|February 1, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trialJanet A Dunn, Peter Donnelly, Nada Elbeltagi, et al.
Pageof 1